2011
DOI: 10.1007/s11434-011-4742-2
|View full text |Cite
|
Sign up to set email alerts
|

Pathway-based analysis for genome-wide association studies of schizophrenia to provide new insight in schizophrenia study

Abstract: Schizophrenia (SZ) is an inheritable complex mental disease. There have been several genome-wide association studies (GWASs) of SZ to identify novel genetic susceptibility factors. To further interpret SZ GWASs, pathway-based analysis (PBA), which considers the combined effect of variants and identifies pathways associated with traits, provides a feasible solution to discover the biological function and mechanism of SZ. Furthermore, to investigate the common pathways between SZ and bipolar disorder (BD) will h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…Two papers [11,12] are working on the development of a battery specifically capturing neuropsychological endophenotypes for schizophrenia, and how it may help develop a research-oriented programme for studying endophenotypes for neuropsychiatric disorders. There are two papers [13,14] specifically dealing with the analysis issues including novel pathway-based analysis for genome-wide association studies for schizophrenia, and the issues we should pay attention to when applying statistics for endophenotype study. Finally, there is one paper [15] working on the establishment of a consortium for endophenotypes to study neuropsychiatric disorders in mainland China.…”
mentioning
confidence: 99%
“…Two papers [11,12] are working on the development of a battery specifically capturing neuropsychological endophenotypes for schizophrenia, and how it may help develop a research-oriented programme for studying endophenotypes for neuropsychiatric disorders. There are two papers [13,14] specifically dealing with the analysis issues including novel pathway-based analysis for genome-wide association studies for schizophrenia, and the issues we should pay attention to when applying statistics for endophenotype study. Finally, there is one paper [15] working on the establishment of a consortium for endophenotypes to study neuropsychiatric disorders in mainland China.…”
mentioning
confidence: 99%